Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000306049 | SCV000480267 | likely benign | Hyper-IgE syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003761957 | SCV001727200 | benign | Autosomal recessive hyper-IgE syndrome | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001701002 | SCV002575556 | likely benign | not provided | 2022-01-21 | criteria provided, single submitter | clinical testing | See Variant Classification Assertion Criteria. |
Gene |
RCV000484654 | SCV000567959 | likely benign | not specified | 2017-07-11 | flagged submission | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genome Diagnostics Laboratory, |
RCV001701002 | SCV001926447 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001701002 | SCV001967326 | likely benign | not provided | no assertion criteria provided | clinical testing |